课题基金 / 基金详情

Cotton Rat: Animal Model Predictive of Clinical Responses to HSV Vaccines

Cotton Rat: Animal Model Predictive of Clinical Responses to HSV Vaccines
棉鼠:预测 HSV 疫苗临床反应的动物模型
批准号:
8000121
负责人:
Marina S Boukhvalova
金额:
$2.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2010-10-31

项目摘要

项目成果

Marina S Boukhvalova的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):生殖器疱疹是全世界最流行的性传播感染之一,与相当大的发病率有关。生殖器疱疹作为公共卫生威胁的影响被放大,因为它与艾滋病毒具有流行病学协同效应。流行病学研究一直表明,单纯疱疹病毒感染增加了艾滋病毒传播和感染的风险。日益普遍的原发单纯疱疹病毒感染、临床复发和高静默复发率加剧了单纯疱疹病毒和艾滋病毒的传播,突出了对新的预防策略的迫切需要。然而,HSV疫苗的开发一直难以捉摸,然而,由葛兰素史克(GSK)开发的HSV-2糖蛋白D(GD)亚单位疫苗的两项试验取得了最有希望的结果,该疫苗为基线水平HSV-1和HSV-2血清阴性的女性提供了部分保护,但未能保护男性或HSV-1血清阳性女性。为了解决目前模型的局限性和不足,我们建立了雌性(阴道)和雄性(阴茎皮肤破裂)棉鼠生殖器疱疹模型。我们还建立了口腔和眼部HSV-1感染模型,从而提供了比较HSV-1血清阳性和HSV-1幼稚动物的疫苗反应的机会。棉鼠的其他优势包括可以用来研究体液和细胞、粘膜和系统免疫反应的试剂。这一第一阶段STTR的总体目标是通过比较GSK GD亚单位疫苗在雄性和雌性棉鼠中的效力来确定棉鼠是否提供了一个预测疫苗临床反应的模型。我们假设,与男性相比,疫苗将在HSV幼稚女性中提供更大的保护,与HSV-1血清阳性女性相比,在HSV-1女性中将提供更大的保护,从而概括了人类临床试验中发生的事情。我们将比较疫苗对初次感染和疾病、临床和亚临床复发率以及粘膜和全身体液和细胞免疫反应的影响。所获得的结果将提供对特定性别反应的潜在机制的洞察,并为未来评估下一代疫苗和其他预防战略的研究建立框架。 公共卫生相关性:生殖器疱疹是全世界最流行的性传播感染之一,与相当大的发病率有关。流行病学研究一直表明,单纯疱疹病毒感染增加了艾滋病毒传播和感染的风险。然而,HSV疫苗的开发一直难以捉摸,然而,由葛兰素史克(GSK)开发的糖蛋白D(GD)亚单位疫苗的两项试验取得了最有希望的结果,该疫苗为基线水平HSV-1和HSV-2血清阴性的女性提供了部分保护,但未能保护男性或HSV-1血清阳性女性。为了解决目前模型的局限性和不足,我们建立了雌性(阴道)和雄性(阴茎皮肤破裂)棉鼠生殖器疱疹模型。这一STTR应用的第一阶段的目标是比较GSK GD-2-单磷酰脂A(MPL)疫苗在雌性和雄性棉鼠中的效果。
英文摘要
DESCRIPTION (provided by applicant): Genital herpes is one of the most prevalent sexually transmitted infections worldwide and is associated with substantial morbidity. The impact of genital herpes as a public health threat is amplified because of its epidemiologic synergy with HIV. Epidemiological studies consistently demonstrate that HSV infection increases the risk of HIV transmission and acquisition. The increasing prevalence of primary HSV infection, clinical recurrences and high rates of silent reactivation fuel the spread of both HSV and HIV and highlight the urgent need for novel prevention strategies. HSV vaccine development has been elusive, however, the most promising results were obtained in two trials with a HSV-2 glycoprotein D (gD) subunit vaccine developed by GlaxoSmithKline (GSK) in which the vaccine provided partial protection for women who were seronegative for both HSV-1 and HSV-2 at baseline, but failed to protect men or to protect HSV-1 seropositive women. To address the limitations and inadequacies of the current models, we established female (vaginal) and male (disrupted penile skin) cotton rat models of genital herpes. We have also established models of oral and ocular HSV- 1 infection, thus providing the opportunity to compare vaccine responses in HSV-1 seropositive and HSV-1 naive animals. Additional advantages of the cotton rat include the availability of reagents to study humoral and cellular mucosal and systemic immune responses. The overall goal of this Phase I STTR is to determine if the cotton rat provides a model predictive of clinical responses to vaccines by comparing the efficacy of the GSK gD subunit vaccine in male and female cotton rats. We hypothesize that the vaccine will provide greater protection in HSV-naive females compared to males and in HSV-1 naove compared to HSV-1 seropositive females, thus recapitulating what happened in the human clinical trials. We will compare the impact of the vaccine on primary infection and disease, rates of clinical and subclinical recurrences, and mucosal and systemic humoral and cellular immune responses. Results obtained will provide insights into the mechanisms underlying gender specific responses and establish the framework for future studies to evaluate next generation vaccines as well as other prevention strategies. PUBLIC HEALTH RELEVANCE: Genital herpes is one of the most prevalent sexually transmitted infections worldwide and is associated with substantial morbidity. Epidemiological studies consistently demonstrate that HSV infection increases the risk of HIV transmission and acquisition. HSV vaccine development has been elusive, however, the most promising results were obtained in two trials with a glycoprotein D (gD) subunit vaccine developed by GlaxoSmithKline (GSK) in which the vaccine provided partial protection for women who were seronegative for both HSV-1 and HSV-2 at baseline, but failed to protect men or to protect HSV-1 seropositive women. To address the limitations and inadequacies of the current models, we established female (vaginal) and male (disrupted penile skin) cotton rat models of genital herpes. The goal of Phase 1 of this STTR application is to compare the efficacy of the GSK gD-2-Alum monophosphoryl lipid A (MPL) vaccine in female and male cotton rats.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Cotton Rat: Translational Model of Influenza Vaccines for the Elderly
  • 批准号:
    8396467
  • 项目类别:
  • 资助金额:
    $27.32万
  • 财政年份:
    2012
  • 负责人:
    Marina S Boukhvalova
  • 依托单位:
The Cotton Rat: Translational Model of Influenza Vaccines for the Elderly
  • 批准号:
    8516959
  • 项目类别:
  • 资助金额:
    $27.32万
  • 财政年份:
    2012
  • 负责人:
    Marina S Boukhvalova
  • 依托单位:
Effect of immunosenescence on innate immune responses to RSV
  • 批准号:
    8194503
  • 项目类别:
  • 资助金额:
    $22.76万
  • 财政年份:
    2010
  • 负责人:
    Marina S Boukhvalova
  • 依托单位:
Cotton Rat: Animal Model Predictive of Clinical Responses to HSV Vaccines
  • 批准号:
    8194517
  • 项目类别:
  • 资助金额:
    $24.63万
  • 财政年份:
    2010
  • 负责人:
    Marina S Boukhvalova
  • 依托单位:
海外基金